These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 25205860

  • 1. Reliability of the mouse model of choroidal neovascularization induced by laser photocoagulation.
    Poor SH, Qiu Y, Fassbender ES, Shen S, Woolfenden A, Delpero A, Kim Y, Buchanan N, Gebuhr TC, Hanks SM, Meredith EL, Jaffee BD, Dryja TP.
    Invest Ophthalmol Vis Sci; 2014 Sep 09; 55(10):6525-34. PubMed ID: 25205860
    [Abstract] [Full Text] [Related]

  • 2. Suppression of laser-induced choroidal neovascularization by nontargeted siRNA.
    Ashikari M, Tokoro M, Itaya M, Nozaki M, Ogura Y.
    Invest Ophthalmol Vis Sci; 2010 Jul 09; 51(7):3820-4. PubMed ID: 20130283
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of experimental choroidal neovascularization in mice by anti-VEGFA/VEGFR2 or non-specific siRNA.
    Gu L, Chen H, Tuo J, Gao X, Chen L.
    Exp Eye Res; 2010 Sep 09; 91(3):433-9. PubMed ID: 20599960
    [Abstract] [Full Text] [Related]

  • 4. Angiostatic effect of CXCR3 expressed on choroidal neovascularization.
    Fujimura S, Takahashi H, Yuda K, Ueta T, Iriyama A, Inoue T, Kaburaki T, Tamaki Y, Matsushima K, Yanagi Y.
    Invest Ophthalmol Vis Sci; 2012 Apr 18; 53(4):1999-2006. PubMed ID: 22408007
    [Abstract] [Full Text] [Related]

  • 5. Laser-induced choroidal neovascularization in mice attenuated by deficiency in the apelin-APJ system.
    Hara C, Kasai A, Gomi F, Satooka T, Sakimoto S, Nakai K, Yoshioka Y, Yamamuro A, Maeda S, Nishida K.
    Invest Ophthalmol Vis Sci; 2013 Jun 21; 54(6):4321-9. PubMed ID: 23722395
    [Abstract] [Full Text] [Related]

  • 6. Suppression of laser-induced choroidal neovascularization by a CCR3 antagonist.
    Mizutani T, Ashikari M, Tokoro M, Nozaki M, Ogura Y.
    Invest Ophthalmol Vis Sci; 2013 Feb 28; 54(2):1564-72. PubMed ID: 23404125
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Intravitreal Stanniocalcin-1 Enhances New Blood Vessel Growth in a Rat Model of Laser-Induced Choroidal Neovascularization.
    Zhao M, Xie W, Tsai SH, Hein TW, Rocke BA, Kuo L, Rosa RH.
    Invest Ophthalmol Vis Sci; 2018 Feb 01; 59(2):1125-1133. PubMed ID: 29490350
    [Abstract] [Full Text] [Related]

  • 11. Optimization of laser-induced choroidal neovascularization in African green monkeys.
    Goody RJ, Hu W, Shafiee A, Struharik M, Bartels S, López FJ, Lawrence MS.
    Exp Eye Res; 2011 Jun 01; 92(6):464-72. PubMed ID: 21414311
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of TNF-alpha reduces laser-induced choroidal neovascularization.
    Shi X, Semkova I, Müther PS, Dell S, Kociok N, Joussen AM.
    Exp Eye Res; 2006 Dec 01; 83(6):1325-34. PubMed ID: 16959248
    [Abstract] [Full Text] [Related]

  • 13. Development of laser-induced choroidal neovascularization in rats after retinal damage by sodium iodate injection.
    García-Layana A, Vásquez G, Salinas-Alamán A, Moreno-Montañés J, Recalde S, Fernández-Robredo P.
    Ophthalmic Res; 2009 Dec 01; 42(4):205-12. PubMed ID: 19672129
    [Abstract] [Full Text] [Related]

  • 14. Suppression of choroidal neovascularization and quantitative and qualitative inhibition of VEGF and CCL2 by heparin.
    Tomida D, Nishiguchi KM, Kataoka K, Yasuma TR, Iwata E, Uetani R, Kachi S, Terasaki H.
    Invest Ophthalmol Vis Sci; 2011 May 16; 52(6):3193-9. PubMed ID: 21296829
    [Abstract] [Full Text] [Related]

  • 15. Inhibitory effect of TNP-470 on experimental choroidal neovascularization in a rat model.
    Ishida K, Yoshimura N, Mandai M, Honda Y.
    Invest Ophthalmol Vis Sci; 1999 Jun 16; 40(7):1512-9. PubMed ID: 10359334
    [Abstract] [Full Text] [Related]

  • 16. Tissue kallikrein attenuates choroidal neovascularization via cleavage of vascular endothelial growth factor.
    Fukuhara J, Noda K, Murata M, Namba S, Kinoshita S, Dong Z, Ando R, Lennikov A, Kanda A, Ishida S.
    Invest Ophthalmol Vis Sci; 2013 Jan 09; 54(1):274-9. PubMed ID: 23233257
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Antiangiogenic effects of axitinib, an inhibitor of vascular endothelial growth factor receptor tyrosine kinase, on laser-induced choroidal neovascularization in mice.
    Kang S, Roh CR, Cho WK, Park KC, Yang KJ, Choi HS, Kim SH, Roh YJ.
    Curr Eye Res; 2013 Jan 09; 38(1):119-27. PubMed ID: 23013553
    [Abstract] [Full Text] [Related]

  • 19. Suppression of choroidal neovascularization by inhibiting angiotensin-converting enzyme: minimal role of bradykinin.
    Nagai N, Oike Y, Izumi-Nagai K, Koto T, Satofuka S, Shinoda H, Noda K, Ozawa Y, Inoue M, Tsubota K, Ishida S.
    Invest Ophthalmol Vis Sci; 2007 May 09; 48(5):2321-6. PubMed ID: 17460297
    [Abstract] [Full Text] [Related]

  • 20. Anti-angiogenic effect of the basement membrane protein nidogen-1 in a mouse model of choroidal neovascularization.
    Semkova I, Kociok N, Karagiannis D, Nischt R, Smyth N, Paulsson M, Strauß O, Joussen AM.
    Exp Eye Res; 2014 Jan 09; 118():80-8. PubMed ID: 24280453
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.